MetLife Investment Management, LLC
Position in CHRS — Coherus Oncology, Inc.
CIK 1529735
Whippany, NJ
Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$110,058
+$44,127 QoQ
Shares Held
78,613
+101.5% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 147 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. CHRS ranks #234 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in CHRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,058 | 78,613 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $65,931 | 39,013 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $104,431 | 63,678 | Shares | Defined | 2025-11-13 | |
| 2024-12-31 | $100,876 | 73,099 | Shares | Defined | 2025-02-13 | |
| 2024-06-30 | $108,481 | 62,706 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $129,428 | 54,154 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $176,922 | 53,130 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $198,706 | 53,130 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $166,064 | 38,891 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $266,014 | 38,891 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $308,016 | 38,891 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $373,742 | 38,891 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $252,589 | 34,888 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $450,404 | 34,888 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $340,331 | 21,324 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $342,676 | 21,324 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $294,910 | 21,324 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $311,543 | 21,324 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $493,696 | 28,406 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $520,966 | 28,406 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $507,331 | 28,406 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $460,745 | 28,406 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||